Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Other Working Capital Changes (2018 - 2025)

TransMedics has reported Other Working Capital Changes over the past 8 years, most recently at $5.9 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $5.9 million for Q4 2025, up 1466.74% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (up 1951.72% YoY), and the annual figure for FY2025 was $3677.0, up 122.31%.
  • Other Working Capital Changes for Q4 2025 was $5.9 million at TransMedics, up from -$1.0 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for TMDX hit a ceiling of $5.9 million in Q4 2025 and a floor of -$3.7 million in Q4 2023.
  • Median Other Working Capital Changes over the past 5 years was -$249500.0 (2021), compared with a mean of -$26600.0.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 4686.15% in 2022 and later soared 1466.74% in 2025.
  • TransMedics' Other Working Capital Changes stood at -$65000.0 in 2021, then tumbled by 4686.15% to -$3.1 million in 2022, then decreased by 20.35% to -$3.7 million in 2023, then skyrocketed by 88.51% to -$430000.0 in 2024, then surged by 1466.74% to $5.9 million in 2025.
  • The last three reported values for Other Working Capital Changes were $5.9 million (Q4 2025), -$1.0 million (Q3 2025), and -$1.4 million (Q2 2025) per Business Quant data.